National Medicines Policy Review
PVI believes it is critical that the principles enshrine the agency and diversity of consumers, and objectives such as ‘timely access’ reflect consumer perspectives and priorities.
Response to Medical Research Futures Fund Priorities 2018-2020 Consultation Discussion Paper 31 August 2018
PVI recommended explicitly require consumer engagement in all research projects; projects to build a robust evidence base about health consumers’ needs, preferences, perspectives and experiences; and developing social science and health economic researchers alongside traditional health researchers.
Response to Consultation: Whether the TGA should publish that a prescription medicine is under evaluation Transparency reforms 29 March 2019
PVI values transparency to nurture informed, active health consumers who have confidence in their health system. PVI’s preference was for all entities to be published on acceptance for evaluation. Includes comments on each option.